InvestorsHub Logo
Followers 6
Posts 355
Boards Moderated 0
Alias Born 12/30/2015

Re: None

Wednesday, 03/01/2017 1:55:48 PM

Wednesday, March 01, 2017 1:55:48 PM

Post# of 404139
SOURCE FinancialBuzz
NEW YORK, February 14, 2017 /PRNewswire/ --
According to a report by Grand View Research, Inc. the global biotechnology market size is expected to reach USD 604.40 billion by 2020. This is due to increasing demand for sophisticated biotech based diagnostic and therapeutic solutions. For example, recombinant technology, red biotechnology, DNA sequencing and many more are expected to serve as a high impact rendering driver during the forecasted period. An emphasis is put on the importance of the presence of government funded institutions such as the NBTB (National Biotechnology Board) and DBT (Department of Biotechnology) which are carrying out R&D and product development exercises pertaining to this field. Funding and scientific updates rendered by these institutions are likely to boost market growth over the forecast period. Mount Tam Biotechnologies, Inc. (OTC: MNTM), Elite Pharmaceuticals Inc. (OTC: ELTP), CytoDyn Inc. (OTC: CYDY), Arch Therapeutics Inc. (OTC: ARTH), Pharmacyte Biotech Inc. (OTC: PMCB)

Missed this one, it is from mid February but still any mention of Elite is good especially when associated with a $604 BILLION market!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News